Allervie Clinical Research — Birmingham, Alabama

Allervie Clinical Research is a clinical research site located in Birmingham, Alabama, United States 35209.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Allervie Clinical Research has participated in 13 clinical trials with 7 currently active.

Therapeutic areas: Chronic Spontaneous Urticaria, Allergy, Peanut, Atopic Dermatitis.

Sponsors: Novartis Pharmaceuticals, Pfizer, Astria Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allervie Clinical Research?

Allervie Clinical Research has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allervie Clinical Research conducted?

Allervie Clinical Research has 13 clinical trials on record, with 7 currently active. Their work covers Chronic Spontaneous Urticaria, Allergy, Peanut, Atopic Dermatitis.

Is Allervie Clinical Research accredited by Crixeo Health?

Yes — Allervie Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Allervie Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.